Attached files
| file | filename |
|---|---|
| 10-K - 10-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | crl1228201910-k.htm |
| EX-32.1 - EXHIBIT 32.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | crl1228201910-kxex321.htm |
| EX-31.2 - EXHIBIT 31.2 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | crl1228201910-kxex312.htm |
| EX-31.1 - EXHIBIT 31.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | crl1228201910-kxex311.htm |
| EX-21.1 - EXHIBIT 21.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | crl1228201910-kxex211.htm |
| EX-4.2 - EXHIBIT 4.2 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | crl1228201910-kxex42.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-224756) and Form S-8 (No. 333-225046, No. 333-212507, No. 333-190292, No. 333-174971, No. 333-161024, No. 333-144177) of Charles River Laboratories International, Inc. of our report dated February 11, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 11, 2020